Sleep Apnea Devices Market Size, Share & Trends by products (Therapeutic (PAP ), Facial Interfaces, Oral Appliances, Accessories), Diagnostic Devices, Age Group, Gender type, End User & Region - Global Forecasts to 2029

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 STUDY SCOPE
  • 1.3.1 SEGMENTS COVERED
  • 1.3.2 REGIONS COVERED
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 List of key secondary sources
    • 2.1.1.2 Key data from secondary sources
    • 2.1.1.3 Objectives of secondary research
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 List of key primaries
    • 2.1.2.2 Objectives of primary research
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Key data from primary sources
    • 2.1.2.5 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Company revenue estimation approach
    • 2.2.1.2 Company presentations and primary interviews
    • 2.2.1.3 Patient-based approach (sleep apnea oral appliances)
    • 2.2.1.4 Patient-based approach (PAP devices)
    • 2.2.1.5 Growth forecast
    • 2.2.1.6 CAGR projections
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 DATA TRIANGULATION
• 2.4 MARKET SHARE ANALYSIS
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 SLEEP APNEA DEVICES MARKET OVERVIEW
• 4.2 SLEEP APNEA DEVICES MARKET, BY PRODUCT (2024-2029)
• 4.3 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT AND COUNTRY (2023)
• 4.4 GEOGRAPHIC GROWTH OPPORTUNITIES (2024-2029)

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Large pool of undiagnosed sleep apnea patients
    • 5.2.1.2 Favorable reimbursement and financial aid for sleep apnea devices and therapies
    • 5.2.1.3 Growing awareness about effects of untreated sleep apnea among patients
    • 5.2.1.4 Increasing usage of oral appliances among patients with mild-to-moderate sleep apnea
    • 5.2.1.5 Increased investments and funding to develop advanced sleep apnea products
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of CPAP machines and minimal insurance access in emerging economies
    • 5.2.2.2 Complex referral pathways, long waiting periods, and delayed diagnosis
    • 5.2.2.3 Use of alternative therapies and medications for sleep apnea
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Rising demand for cost-effective home sleep apnea tests
    • 5.2.3.2 Increasing focus on telemedicine, mHealth, and artificial intelligence
    • 5.2.3.3 Growing focus of key sleep apnea device manufacturers toward emerging markets
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Poor patient compliance with CPAP therapy
• 5.3 PRICING ANALYSIS
  • 5.3.1 AVERAGE SELLING PRICE OF SLEEP APNEA PRODUCTS, BY REGION
  • 5.3.2 AVERAGE SELLING PRICE RANGE, BY PRODUCT TYPE
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 PORTER'S FIVE FORCES ANALYSIS
  • 5.6.1 THREAT OF NEW ENTRANTS
  • 5.6.2 THREAT OF SUBSTITUTES
  • 5.6.3 BARGAINING POWER OF SUPPLIERS
  • 5.6.4 BARGAINING POWER OF BUYERS
  • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.7 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.7.2 KEY BUYING CRITERIA
• 5.8 ECOSYSTEM ANALYSIS
  • 5.8.1 ROLE IN ECOSYSTEM
• 5.9 REGULATORY ANALYSIS
  • 5.9.1 REGULATORY LANDSCAPE
    • 5.9.1.1 North America
      • 5.9.1.1.1 US
        • 5.9.1.1.1.1 Reimbursement scenario in US
      • 5.9.1.1.2 Canada
    • 5.9.1.2 Europe
    • 5.9.1.3 Asia Pacific
      • 5.9.1.3.1 Japan
      • 5.9.1.3.2 China
      • 5.9.1.3.3 India
      • 5.9.1.3.4 Australia
  • 5.9.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.9.2.1 List of key regulatory bodies, government agencies, and other organizations
      • 5.9.2.1.1 North America
      • 5.9.2.1.2 Europe
      • 5.9.2.1.3 Asia Pacific
      • 5.9.2.1.4 Latin America
      • 5.9.2.1.5 Middle East & Africa
    • 5.9.2.2 List of other regulatory bodies, government agencies, and other organizations
• 5.1 PATENT ANALYSIS
• 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.11.1 REVENUE SHIFT AND POCKETS FOR SLEEP APNEA ORAL APPLIANCE MANUFACTURERS
• 5.12 KEY CONFERENCES & EVENTS, 2024-2025
• 5.13 TECHNOLOGY ANALYSIS
  • 5.13.1 KEY TECHNOLOGIES
    • 5.13.1.1 PAP devices
  • 5.13.2 ADJACENT TECHNOLOGIES
    • 5.13.2.1 Oral appliances
• 5.14 TRADE ANALYSIS
  • 5.14.1 IMPORT DATA FOR HS CODE 901920
  • 5.14.2 EXPORT DATA FOR HS CODE 901920
• 5.15 INVESTMENT & FUNDING SCENARIO
• 5.16 IMPACT OF GENERATIVE AI ON SLEEP APNEA DEVICES MARKET

6 EPIDEMIOLOGICAL ASSESSMENT OF SLEEP APNEA

• 6.1 INTRODUCTION
• 6.2 EPIDEMIOLOGICAL ASSESSMENT
• 6.3 PRESCRIPTION PATTERN ASSESSMENT
• 6.4 ADHERENCE ASSESSMENT

7 ALTERNATE THERAPIES FOR SLEEP APNEA

• 7.1 INTRODUCTION
• 7.2 EXPIRATORY PAP
• 7.3 HYPOGLOSSAL NERVE STIMULATION
• 7.4 ORAL PRESSURE THERAPY
• 7.5 POSITIONAL THERAPY

8 SLEEP APNEA DEVICES MARKET, BY PRODUCT

• 8.1 INTRODUCTION
• 8.2 THERAPEUTIC DEVICES
  • 8.2.1 PAP DEVICES
  • 8.2.2 CPAP DEVICES
    • 8.2.2.1 Technological advancements and better reimbursement facilities to boost segment growth
  • 8.2.3 APAP DEVICES
    • 8.2.3.1 Increasing patient non-compliance with CPAP devices to augment segment growth
  • 8.2.4 BPAP DEVICES
    • 8.2.4.1 Increased product recalls and more complex operations to lower adoption
  • 8.2.5 FACIAL INTERFACES
    • 8.2.5.1 Masks
      • 8.2.5.1.1 Full-face masks
        • 8.2.5.1.1.1 Full-face masks to be most effective for mouth breathers or patients struggling with breathing through nose
      • 8.2.5.1.2 Nasal pillow masks
        • 8.2.5.1.2.1 Greater patient compliance and high preference for masks without headgear or straps to support segment
      • 8.2.5.1.3 Nasal masks
        • 8.2.5.1.3.1 Ease of use and less claustrophobic nature to aid adoption
    • 8.2.5.2 Cushions
      • 8.2.5.2.1 Favorable insurance coverage to propel segment growth
  • 8.2.6 ACCESSORIES
    • 8.2.6.1 Humidifier accessories
      • 8.2.6.1.1 Humidifiers to open airways, decrease congestion, and encourage clearer breathing
    • 8.2.6.2 Power accessories
      • 8.2.6.2.1 Power accessories to manage uninterrupted sleep apnea therapy in absence of power supply
    • 8.2.6.3 Transportation accessories
      • 8.2.6.3.1 Need to carry sleep apnea devices while traveling to spur segment growth
    • 8.2.6.4 Communication accessories
      • 8.2.6.4.1 Increasing need for easy teleconsultations for remote patients to fuel segment growth
    • 8.2.6.5 Chain restraints
      • 8.2.6.5.1 Growing need for obstructive sleep apnea management with therapeutic devices to drive segment
    • 8.2.6.6 Other accessories
  • 8.2.7 ORAL APPLIANCES
    • 8.2.7.1 Mandibular advancement devices
      • 8.2.7.1.1 Low cost and better research on device advantages to propel market growth
    • 8.2.7.2 Tongue-retaining devices
      • 8.2.7.2.1 Need for more affordable and comfortable treatment options to support segment growth
    • 8.2.7.3 Daytime-Nighttime appliances
      • 8.2.7.3.1 Increased focus on comfortable, non-surgical, and low-risk treatments to drive segment
  • 8.2.8 OTHER THERAPEUTIC DEVICES
• 8.3 DIAGNOSTIC DEVICES
  • 8.3.1 PSG DEVICES
    • 8.3.1.1 Ambulatory PSG devices
      • 8.3.1.1.1 High need for cost-effective and technologically advanced devices to propel segment growth
    • 8.3.1.2 Clinical PSG devices
      • 8.3.1.2.1 Labor-intensive and expensive procedures to limit segment
  • 8.3.2 HOME SLEEP TESTING DEVICES
    • 8.3.2.1 Increased need for cost-effective and comfortable home sleep testing devices to augment segment growth
  • 8.3.3 OXIMETERS
    • 8.3.3.1 Fingertip oximeters
      • 8.3.3.1.1 Lack of precise reading due to injury or slow blood flow to limit segment
    • 8.3.3.2 Handheld oximeters
      • 8.3.3.2.1 Easy customizations and ease of distant reading to spur segment growth
    • 8.3.3.3 Wrist-worn oximeters
      • 8.3.3.3.1 Small size and easy portability for overnight monitoring to propel segment growth
    • 8.3.3.4 Tabletop oximeters
      • 8.3.3.4.1 Higher cost and fewer applications for personal use to decrease market share
  • 8.3.4 ACTIGRAPHY SYSTEMS
    • 8.3.4.1 Increased research on sleep and wake patterns to drive market
  • 8.3.5 SLEEP SCREENING DEVICES
    • 8.3.5.1 Increasing preference for home-based sleep apnea testing to propel market growth

9 SLEEP APNEA DEVICES MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 SLEEP LABORATORIES, CLINICS, AND HOSPITALS
  • 9.2.1 INCREASING NEED FOR ADVANCED DIAGNOSTIC DEVICES AND HIGHLY PRECISE DIAGNOSIS TO SUPPORT MARKET GROWTH
• 9.3 HOME CARE SETTINGS/INDIVIDUALS
  • 9.3.1 INCREASING PATIENT PREFERENCE FOR HOME-BASED SLEEP TESTS TO FUEL MARKET GROWTH

10 SLEEP APNEA DEVICES MARKET, BY AGE GROUP

• 10.1 INTRODUCTION
• 10.2 BELOW 40 YEARS
  • 10.2.1 LOWER PREVALENCE OF SLEEP APNEA IN YOUNGER AGE GROUPS TO LIMIT MARKET GROWTH
• 10.3 40-60 YEARS
  • 10.3.1 UNDERDIAGNOSIS AND UNHEALTHY LIFESTYLE TO AID MARKET GROWTH
• 10.4 ABOVE 60 YEARS
  • 10.4.1 HIGH OCCURRENCE OF CHRONIC MEDICAL CONDITIONS AND SLEEP-RELATED DISORDERS TO DRIVE MARKET

11 SLEEP APNEA DEVICES MARKET, BY GENDER

• 11.1 INTRODUCTION
• 11.2 MALE PATIENTS
  • 11.2.1 HIGHER PREVALENCE OF SLEEP-RELATED BREATHING DISORDERS TO BOOST MARKET GROWTH
• 11.3 FEMALE PATIENTS
  • 11.3.1 UNDERDIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA TO LIMIT MARKET

12 SLEEP APNEA DEVICES MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 US
    • 12.2.1.1 US to dominate North American sleep apnea devices market during forecast period
  • 12.2.2 CANADA
    • 12.2.2.1 Increasing number of research grants and health programs to propel market growth
• 12.3 EUROPE
  • 12.3.1 GERMANY
    • 12.3.1.1 High prevalence of obstructive sleep apnea and increased geriatric population to fuel market
  • 12.3.2 UK
    • 12.3.2.1 Rising awareness among patients about sleep apnea to support market growth
  • 12.3.3 FRANCE
    • 12.3.3.1 Rising geriatric population and obesity rates to fuel market growth
  • 12.3.4 ITALY
    • 12.3.4.1 Favorable initiatives by dental associations and increased awareness about obstructive sleep apnea to drive market
  • 12.3.5 SPAIN
    • 12.3.5.1 Social awareness initiatives by regional organizations to aid market growth
  • 12.3.6 REST OF EUROPE
• 12.4 ASIA PACIFIC
  • 12.4.1 CHINA
    • 12.4.1.1 Growing obesity and diabetes in adults to propel market growth
  • 12.4.2 JAPAN
    • 12.4.2.1 Favorable reimbursement scenario and high demand for cloud-connected sleep apnea therapeutic devices to aid market growth
  • 12.4.3 AUSTRALIA
    • 12.4.3.1 Increased number of sleep clinics to augment market growth
  • 12.4.4 REST OF ASIA PACIFIC
• 12.5 LATIN AMERICA
  • 12.5.1 BRAZIL
    • 12.5.1.1 Favorable reimbursement policies and increased awareness about sleeping disorders to drive market
  • 12.5.2 MEXICO
    • 12.5.2.1 Poor healthcare infrastructure and lack of public health initiatives to limit market growth
  • 12.5.3 REST OF LATIN AMERICA
• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 PRESENCE OF KEY INTERNATIONAL PLAYERS AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
• 12.7 GCC COUNTRIES
  • 12.7.1 SAUDI ARABIA
    • 12.7.1.1 High obesity rates among women to propel market growth
  • 12.7.2 UAE
    • 12.7.2.1 Improved access to diagnostics to drive adoption of sleep apnea devices
• 12.8 REST OF GCC COUNTRIES

13 COMPETITIVE LANDSCAPE

• 13.1 INTRODUCTION
• 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP APNEA DEVICES MARKET
• 13.3 REVENUE ANALYSIS
• 13.4 MARKET SHARE ANALYSIS
• 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 13.5.1 STARS
  • 13.5.2 EMERGING LEADERS
  • 13.5.3 PERVASIVE PLAYERS
  • 13.5.4 PARTICIPANTS
  • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 13.5.5.1 Company footprint
    • 13.5.5.2 Product footprint
    • 13.5.5.3 Region footprint
• 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 13.6.1 PROGRESSIVE COMPANIES
  • 13.6.2 RESPONSIVE COMPANIES
  • 13.6.3 DYNAMIC COMPANIES
  • 13.6.4 STARTING BLOCKS
  • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 13.7 COMPANY VALUATION & FINANCIAL METRICS
• 13.8 BRAND/PRODUCT COMPARISON
• 13.9 COMPETITIVE SCENARIO
  • 13.9.1 PRODUCT LAUNCHES & APPROVALS
  • 13.9.2 DEALS
  • 13.9.3 EXPANSIONS
  • 13.9.4 OTHER DEVELOPMENTS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
  • 14.1.1 RESMED
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products offered
    • 14.1.1.3 Recent developments
      • 14.1.1.3.1 Product launches
      • 14.1.1.3.2 Deals
      • 14.1.1.3.3 Expansions
    • 14.1.1.4 MnM view
      • 14.1.1.4.1 Key strengths
      • 14.1.1.4.2 Strategic choices
      • 14.1.1.4.3 Weaknesses & competitive threats
  • 14.1.2 KONINKLIJKE PHILIPS N.V.
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products offered
    • 14.1.2.3 MnM view
      • 14.1.2.3.1 Key strengths
      • 14.1.2.3.2 Strategic choices
      • 14.1.2.3.3 Weaknesses & competitive threats
  • 14.1.3 FISHER & PAYKEL HEALTHCARE LIMITED
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products offered
    • 14.1.3.3 Recent developments
      • 14.1.3.3.1 Product launches
    • 14.1.3.4 MnM view
      • 14.1.3.4.1 Key strengths
      • 14.1.3.4.2 Strategic choices
      • 14.1.3.4.3 Weaknesses & competitive threats
  • 14.1.4 INSPIRE MEDICAL SYSTEMS, INC.
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products offered
  • 14.1.5 SOMNOMED
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products offered
  • 14.1.6 OPENAIRWAY
    • 14.1.6.1 Business overview
    • 14.1.6.2 Products offered
  • 14.1.7 COMPUMEDICS LIMITED
    • 14.1.7.1 Business overview
    • 14.1.7.2 Products offered
    • 14.1.7.3 Recent developments
      • 14.1.7.3.1 Product approvals
  • 14.1.8 LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG
    • 14.1.8.1 Business overview
    • 14.1.8.2 Products offered
  • 14.1.9 DRIVE DEVILBISS HEALTHCARE
    • 14.1.9.1 Business overview
    • 14.1.9.2 Products offered
  • 14.1.10 BMC MEDICAL CO., LTD.
    • 14.1.10.1 Business overview
    • 14.1.10.2 Products offered
  • 14.1.11 BRAEBON MEDICAL CORPORATION
    • 14.1.11.1 Business overview
    • 14.1.11.2 Products offered
  • 14.1.12 DYNAFLEX
    • 14.1.12.1 Business overview
    • 14.1.12.2 Products offered
    • 14.1.12.3 Recent developments
      • 14.1.12.3.1 Deals
  • 14.1.13 PANTHERA DENTAL
    • 14.1.13.1 Business overview
    • 14.1.13.2 Products offered
    • 14.1.13.3 Recent developments
      • 14.1.13.3.1 Deals
      • 14.1.13.3.2 Other developments
  • 14.1.14 MYERSON LLC
    • 14.1.14.1 Business overview
    • 14.1.14.2 Products offered
  • 14.1.15 PROSOMNUS SLEEP TECHNOLOGIES
    • 14.1.15.1 Business overview
    • 14.1.15.2 Products offered
    • 14.1.15.3 Recent developments
      • 14.1.15.3.1 Deals
• 14.2 OTHER PLAYERS
  • 14.2.1 NIDEK MEDICAL INDIA
  • 14.2.2 TOMED GMBH
  • 14.2.3 LIVANOVA PLC
    • 14.2.3.1 Recent developments
      • 14.2.3.1.1 Product approvals
  • 14.2.4 INVACARE CORPORATION
  • 14.2.5 MPOWRX HEALTH & WELLNESS PRODUCTS INC.
  • 14.2.6 NIHON KOHDEN CORPORATION
  • 14.2.7 SICAT GMBH & CO. KG
  • 14.2.8 VIVOS THERAPEUTICS, INC.
    • 14.2.8.1 Recent developments
      • 14.2.8.1.1 Product approvals
      • 14.2.8.1.2 Deals
      • 14.2.8.1.3 Expansions
  • 14.2.9 AIRWAY MANAGEMENT
    • 14.2.9.1 Recent developments
      • 14.2.9.1.1 Product launches
  • 14.2.10 APNEA SCIENCES

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.3 CUSTOMIZATION OPTIONS
• 15.4 RELATED REPORTS
• 15.5 AUTHOR DETAILS

List of Tables

• TABLE 1 SLEEP APNEA DEVICES MARKET: INCLUSIONS & EXCLUSIONS
• TABLE 2 SLEEP APNEA DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES
• TABLE 3 SLEEP APNEA DEVICES MARKET: RISK ASSESSMENT
• TABLE 4 ESTIMATED PREVALENCE OF SLEEP APNEA, 2022-2024 (MILLION)
• TABLE 5 REIMBURSEMENT CODES AND COSTS OF KEY SLEEP APNEA DEVICES BY RESMED
• TABLE 6 ESTABLISHED CPT CODES PROVIDED BY ITAMAR MEDICAL LTD.
• TABLE 7 INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS OF UNTREATED SLEEP APNEA
• TABLE 8 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING SLEEP APNEA
• TABLE 9 AVERAGE SELLING PRICE OF SLEEP APNEA PRODUCTS, BY REGION
• TABLE 10 AVERAGE SELLING PRICE RANGE, BY PRODUCT TYPE, 2021-2023
• TABLE 11 SLEEP APNEA DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA DEVICES (%)
• TABLE 13 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA DEVICES
• TABLE 14 SLEEP APNEA DEVICES MARKET: ROLE IN ECOSYSTEM
• TABLE 15 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
• TABLE 16 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
• TABLE 17 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
• TABLE 18 CHINA: CLASSIFICATION OF MEDICAL DEVICES
• TABLE 19 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 20 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 21 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 22 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 23 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 24 LIST OF OTHER REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 25 SLEEP APNEA DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2024-DECEMBER 2025
• TABLE 26 IMPORT DATA FOR HS CODE 901920, BY COUNTRY, 2019-2023 (USD MILLION)
• TABLE 27 EXPORT DATA FOR HS CODE 901920, BY COUNTRY, 2019-2023 (USD MILLION)
• TABLE 28 SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 29 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 30 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 31 PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 32 PAP DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 33 CPAP DEVICES OFFERED BY KEY PLAYERS
• TABLE 34 CPAP DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 35 APAP DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 36 BPAP DEVICES OFFERED BY KEY PLAYERS
• TABLE 37 BPAP DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 38 FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 39 FACIAL INTERFACES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 40 MASKS OFFERED BY KEY PLAYERS
• TABLE 41 MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 42 MASKS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 43 FULL-FACE MASKS OFFERED BY KEY PLAYERS
• TABLE 44 FULL-FACE MASKS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 45 NASAL PILLOW MASKS OFFERED BY KEY PLAYERS
• TABLE 46 NASAL PILLOW MASKS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 47 NASAL MASKS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 48 CUSHIONS OFFERED BY KEY PLAYERS
• TABLE 49 CUSHIONS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 50 ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 51 ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 52 HUMIDIFIER ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 53 POWER ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 54 TRANSPORTATION ACCESSORIES MARKET, BY REGION,2022-2029 (USD MILLION)
• TABLE 55 COMMUNICATION ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 56 CHIN RESTRAINTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 57 OTHER ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 58 ORAL APPLIANCES OFFERED BY KEY PLAYERS
• TABLE 59 ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 60 ORAL APPLIANCES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 61 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 62 TONGUE-RETAINING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 63 DAYTIME-NIGHTTIME APPLIANCES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 64 OTHER THERAPEUTIC DEVICES OFFERED BY KEY PLAYERS
• TABLE 65 OTHER THERAPEUTIC DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 66 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 67 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 68 PSG DEVICES OFFERED BY KEY PLAYERS
• TABLE 69 PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 70 PSG DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 71 AMBULATORY PSG DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 72 CLINICAL PSG DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 73 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 74 OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 75 OXIMETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 76 FINGERTIP OXIMETERS OFFERED BY KEY PLAYERS
• TABLE 77 FINGERTIP OXIMETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 78 HANDHELD OXIMETERS OFFERED BY KEY PLAYERS
• TABLE 79 HANDHELD OXIMETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 80 WRIST-WORN OXIMETERS OFFERED BY KEY PLAYERS
• TABLE 81 WRIST-WORN OXIMETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 82 TABLETOP OXIMETERS OFFERED BY KEY PLAYERS
• TABLE 83 TABLETOP OXIMETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 84 LIST OF JOURNALS THAT ASSESS ROLE OF ACTIGRAPHY SYSTEMS IN SLEEP APNEA
• TABLE 85 ACTIGRAPHY SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 86 SLEEP SCREENING DEVICES OFFERED BY KEY PLAYERS
• TABLE 87 SLEEP SCREENING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 88 SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 89 SLEEP APNEA DEVICES MARKET FOR SLEEP LABORATORIES, CLINICS, AND HOSPITALS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 90 SLEEP APNEA DEVICES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS,BY REGION, 2022-2029 (USD MILLION)
• TABLE 91 SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 92 SLEEP APNEA DEVICES MARKET FOR BELOW 40 YEARS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 93 SLEEP APNEA DEVICES MARKET FOR 40-60 YEARS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 94 SLEEP APNEA DEVICES MARKET FOR ABOVE 60 YEARS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 95 SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 96 SLEEP APNEA DEVICES MARKET FOR MALE PATIENTS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 97 SLEEP APNEA DEVICES MARKET FOR FEMALE PATIENTS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 98 SLEEP APNEA DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 99 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 100 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 101 NORTH AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 102 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 103 NORTH AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 104 NORTH AMERICA: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 105 NORTH AMERICA: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 106 NORTH AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 107 NORTH AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 108 NORTH AMERICA: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 109 NORTH AMERICA: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 110 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 111 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 112 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 113 US: SLEEP APNEA PRODUCTS OFFERED BY KEY PLAYERS
• TABLE 114 US: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 115 US: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 116 US: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (THOUSAND UNITS)
• TABLE 117 US: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 118 US: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 119 US: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 120 US: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 121 US: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 122 US: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 123 US: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 124 US: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 125 US: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 126 US: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 127 US: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 128 CANADA: SLEEP APNEA PRODUCTS OFFERED BY KEY PLAYERS
• TABLE 129 CANADA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 130 CANADA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 131 CANADA: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 132 CANADA: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 133 CANADA: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 134 CANADA: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 135 CANADA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 136 CANADA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 137 CANADA: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 138 CANADA: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 139 CANADA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 140 CANADA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 141 CANADA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 142 EUROPE: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 143 EUROPE: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 144 EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 145 EUROPE: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 146 EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 147 EUROPE: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 148 EUROPE: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 149 EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 150 EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 151 EUROPE: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 152 EUROPE: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 153 EUROPE: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 154 EUROPE: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 155 EUROPE: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 156 GERMANY: SLEEP APNEA PRODUCTS PROVIDED BY MAJOR PLAYERS
• TABLE 157 GERMANY: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 158 GERMANY: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 159 GERMANY: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 160 GERMANY: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 161 GERMANY: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 162 GERMANY: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 163 GERMANY: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 164 GERMANY: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 165 GERMANY: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 166 GERMANY: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 167 GERMANY: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 168 GERMANY: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 169 GERMANY: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 170 UK: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 171 UK: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 172 UK: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 173 UK: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 174 UK: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 175 UK: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 176 UK: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 177 UK: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 178 UK: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 179 UK: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 180 UK: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 181 UK: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 182 UK: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 183 FRANCE: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 184 FRANCE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 185 FRANCE: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 186 FRANCE: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 187 FRANCE: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 188 FRANCE: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 189 FRANCE: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 190 FRANCE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 191 FRANCE: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 192 FRANCE: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 193 FRANCE: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 194 FRANCE: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 195 FRANCE: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 196 ITALY: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 197 ITALY: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 198 ITALY: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 199 ITALY: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 200 ITALY: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 201 ITALY: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 202 ITALY: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 203 ITALY: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 204 ITALY: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 205 ITALY: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 206 ITALY: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 207 ITALY: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 208 ITALY: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 209 SPAIN: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 210 SPAIN: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 211 SPAIN: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 212 SPAIN: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 213 SPAIN: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 214 SPAIN: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 215 SPAIN: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 216 SPAIN: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 217 SPAIN: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 218 SPAIN: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 219 SPAIN: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 220 SPAIN: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 221 SPAIN: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 222 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 223 REST OF EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 224 REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 225 REST OF EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 226 REST OF EUROPE: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 227 REST OF EUROPE: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 228 REST OF EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 229 REST OF EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 230 REST OF EUROPE: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 231 REST OF EUROPE: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 232 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 233 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 234 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 235 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 236 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 237 ASIA PACIFIC: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 238 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 239 ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 240 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 241 ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 242 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 243 ASIA PACIFIC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 244 ASIA PACIFIC: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 245 ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 246 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 247 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 248 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 249 CHINA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 250 CHINA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 251 CHINA: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 252 CHINA: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 253 CHINA: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 254 CHINA: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 255 CHINA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 256 CHINA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 257 CHINA: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 258 CHINA: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 259 CHINA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 260 CHINA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 261 CHINA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 262 JAPAN: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 263 JAPAN: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 264 JAPAN: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 265 JAPAN: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 266 JAPAN: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 267 JAPAN: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 268 JAPAN: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 269 JAPAN: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 270 JAPAN: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 271 JAPAN: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 272 JAPAN: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 273 JAPAN: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 274 JAPAN: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 275 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 276 AUSTRALIA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 277 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 278 AUSTRALIA: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 279 AUSTRALIA: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 280 AUSTRALIA: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 281 AUSTRALIA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 282 AUSTRALIA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 283 AUSTRALIA: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 284 AUSTRALIA: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 285 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 286 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 287 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 288 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 289 REST OF ASIA PACIFIC: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 290 REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 291 REST OF ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 292 REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 293 REST OF ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 294 REST OF ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 295 REST OF ASIA PACIFIC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 296 REST OF ASIA PACIFIC: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 297 REST OF ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 298 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 299 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 300 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 301 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 302 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 303 LATIN AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 304 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 305 LATIN AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 306 LATIN AMERICA: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 307 LATIN AMERICA: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 308 LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 309 LATIN AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 310 LATIN AMERICA: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 311 LATIN AMERICA: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 312 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 313 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 314 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 315 BRAZIL: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 316 BRAZIL: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 317 BRAZIL: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 318 BRAZIL: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 319 BRAZIL: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 320 BRAZIL: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 321 BRAZIL: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 322 BRAZIL: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 323 BRAZIL: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 324 BRAZIL: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 325 BRAZIL: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 326 BRAZIL: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 327 BRAZIL: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 328 MEXICO: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 329 MEXICO: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 330 MEXICO: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 331 MEXICO: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 332 MEXICO: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 333 MEXICO: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 334 MEXICO: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 335 MEXICO: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 336 MEXICO: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 337 MEXICO: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 338 MEXICO: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 339 MEXICO: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 340 MEXICO: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 341 REST OF LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 342 REST OF LATIN AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 343 REST OF LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 344 REST OF LATIN AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 345 REST OF LATIN AMERICA: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 346 REST OF LATIN AMERICA: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 347 REST OF LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 348 REST OF LATIN AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 349 REST OF LATIN AMERICA: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 350 REST OF LATIN AMERICA: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 351 REST OF LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 352 REST OF LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,2022-2029 (USD MILLION)
• TABLE 353 REST OF LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 354 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 355 MIDDLE EAST & AFRICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 356 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 357 MIDDLE EAST & AFRICA: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 358 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 359 MIDDLE EAST & AFRICA: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 360 MIDDLE EAST & AFRICA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 361 MIDDLE EAST & AFRICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 362 MIDDLE EAST & AFRICA: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 363 MIDDLE EAST & AFRICA: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 364 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 365 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 366 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 367 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 368 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 369 GCC COUNTRIES: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 370 GCC COUNTRIES: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 371 GCC COUNTRIES: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 372 GCC COUNTRIES: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 373 GCC COUNTRIES: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 374 GCC COUNTRIES: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 375 GCC COUNTRIES: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 376 GCC COUNTRIES: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 377 GCC COUNTRIES: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 378 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 379 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 380 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 381 SAUDI ARABIA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 382 SAUDI ARABIA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 383 SAUDI ARABIA: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 384 SAUDI ARABIA: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 385 SAUDI ARABIA: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 386 SAUDI ARABIA: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 387 SAUDI ARABIA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 388 SAUDI ARABIA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 389 SAUDI ARABIA: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 390 SAUDI ARABIA: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 391 SAUDI ARABIA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 392 SAUDI ARABIA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 393 SAUDI ARABIA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 394 UAE: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 395 UAE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 396 UAE: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 397 UAE: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 398 UAE: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 399 UAE: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 400 UAE: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
• TABLE 401 UAE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
• TABLE 402 UAE: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
• TABLE 403 UAE: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
• TABLE 404 UAE: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
• TABLE 405 UAE: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
• TABLE 406 UAE: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
• TABLE 407 REST OF GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
• TABLE 408 REST OF GCC COUNTRIES: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
• TABLE 409 REST OF GCC COUNTRIES: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
• TABLE 410 REST OF GCC COUNTRIES: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
• TABLE 411 REST OF GCC COUNTRIES: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
• TABLE 412 REST OF GCC COUNTRIES: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
• TABLE 413 REST OF GCC COUNTRIES: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
• TABLE 414 REST OF GCC COUNTRIES: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
• TABLE 415 REST OF GCC COUNTRIES: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
• TABLE 416 REST OF GCC COUNTRIES: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
• TABLE 417 REST OF GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
• TABLE 418 REST OF GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
• TABLE 419 REST OF GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
• TABLE 420 OVERVIEW OF STRATEGIES ADOPTED BY KEY SLEEP APNEA DEVICE MANUFACTURING COMPANIES
• TABLE 421 SLEEP APNEA DEVICES MARKET: DEGREE OF COMPETITION
• TABLE 422 SLEEP APNEA DEVICES MARKET: PRODUCT FOOTPRINT
• TABLE 423 SLEEP APNEA DEVICES MARKET: REGION FOOTPRINT
• TABLE 424 SLEEP APNEA DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
• TABLE 425 SLEEP APNEA DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
• TABLE 426 SLEEP APNEA DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021– JUNE 2024
• TABLE 427 SLEEP APNEA DEVICES MARKET: DEALS, JANUARY 2021– JUNE 2024
• TABLE 428 SLEEP APNEA DEVICES MARKET: EXPANSIONS, JANUARY 2021– JUNE 2024
• TABLE 429 SLEEP APNEA DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
• TABLE 430 RESMED: COMPANY OVERVIEW
• TABLE 431 RESMED: PRODUCTS OFFERED
• TABLE 432 RESMED: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
• TABLE 433 RESMED: DEALS, JANUARY 2021–JUNE 2024
• TABLE 434 RESMED: EXPANSIONS, JANUARY 2021–JUNE 2024
• TABLE 435 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
• TABLE 436 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
• TABLE 437 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW
• TABLE 438 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCTS OFFERED
• TABLE 439 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
• TABLE 440 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
• TABLE 441 INSPIRE MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
• TABLE 442 SOMNOMED: COMPANY OVERVIEW
• TABLE 443 SOMNOMED: PRODUCTS OFFERED
• TABLE 444 OPENAIRWAY: COMPANY OVERVIEW
• TABLE 445 OPENAIRWAY: PRODUCTS OFFERED
• TABLE 446 COMPUMEDICS LIMITED: COMPANY OVERVIEW
• TABLE 447 COMPUMEDICS LIMITED: PRODUCTS OFFERED
• TABLE 448 COMPUMEDICS LIMITED: PRODUCT APPROVALS, JANUARY 2021–JUNE 2024
• TABLE 449 LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG: COMPANY OVERVIEW
• TABLE 450 LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG: PRODUCTS OFFERED
• TABLE 451 DRIVE DEVILBISS HEALTHCARE: COMPANY OVERVIEW
• TABLE 452 DRIVE DEVILBISS HEALTHCARE: PRODUCTS OFFERED
• TABLE 453 BMC MEDICAL CO., LTD.: COMPANY OVERVIEW
• TABLE 454 BMC MEDICAL CO., LTD.: PRODUCTS OFFERED
• TABLE 455 BRAEBON MEDICAL CORPORATION: COMPANY OVERVIEW
• TABLE 456 BRAEBON MEDICAL CORPORATION: PRODUCTS OFFERED
• TABLE 457 DYNAFLEX: COMPANY OVERVIEW
• TABLE 458 DYNAFLEX.: PRODUCTS OFFERED
• TABLE 459 DYNAFLEX: DEALS, JANUARY 2021–JUNE 2024
• TABLE 460 PANTHERA DENTAL: COMPANY OVERVIEW
• TABLE 461 PANTHERA DENTAL: PRODUCTS OFFERED
• TABLE 462 PANTHERA DENTAL: DEALS, JANUARY 2021–JUNE 2024
• TABLE 463 PANTHERA DENTAL: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
• TABLE 464 MYERSON LLC: COMPANY OVERVIEW
• TABLE 465 MYERSON LLC: PRODUCTS OFFERED
• TABLE 466 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY OVERVIEW
• TABLE 467 PROSOMNUS SLEEP TECHNOLOGIES: PRODUCTS OFFERED
• TABLE 468 PROSOMNUS SLEEP TECHNOLOGIES: DEALS, JANUARY 2021–JUNE 2024
• TABLE 469 NIDEK MEDICAL INDIA: COMPANY OVERVIEW
• TABLE 470 TOMED GMBH: COMPANY OVERVIEW
• TABLE 471 LIVANOVA PLC: COMPANY OVERVIEW
• TABLE 472 LIVANOVA PLC: PRODUCT APPROVALS, JANUARY 2021–JUNE 2024
• TABLE 473 INVACARE CORPORATION: COMPANY OVERVIEW
• TABLE 474 MPOWRX HEALTH & WELLNESS PRODUCTS INC.: COMPANY OVERVIEW
• TABLE 475 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
• TABLE 476 SICAT GMBH & CO. KG: COMPANY OVERVIEW
• TABLE 477 VIVOS THERAPEUTICS, INC.: COMPANY OVERVIEW
• TABLE 478 VIVOS THERAPEUTICS, INC.: PRODUCT APPROVALS, JANUARY 2021–JUNE 2024
• TABLE 479 VIVOS THERAPEUTICS, INC.: DEALS, JANUARY 2021–JUNE 2024
• TABLE 480 VIVOS THERAPEUTICS, INC.: EXPANSIONS, JANUARY 2021–JUNE 2024
• TABLE 481 AIRWAY MANAGEMENT: COMPANY OVERVIEW
• TABLE 482 AIRWAY MANAGEMENT: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
• TABLE 483 APNEA SCIENCES: COMPANY OVERVIEW

List of Figures

• FIGURE 1 SLEEP APNEA DEVICES MARKET: SEGMENTS COVERED
• FIGURE 2 SLEEP APNEA DEVICES MARKET: REGIONS COVERED
• FIGURE 3 SLEEP APNEA DEVICES MARKET: YEARS CONSIDERED
• FIGURE 4 SLEEP APNEA DEVICES MARKET: RESEARCH DESIGN
• FIGURE 5 LIST OF KEY PRIMARIES (DEMAND AND SUPPLY SIDES)
• FIGURE 6 SLEEP APNEA DEVICES MARKET: KEY INDUSTRY INSIGHTS
• FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 8 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
• FIGURE 9 BOTTOM-UP APPROACH: PATIENT-BASED ANALYSIS
• FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
• FIGURE 11 SLEEP APNEA DEVICES MARKET: TOP-DOWN APPROACH
• FIGURE 12 DATA TRIANGULATION METHODOLOGY
• FIGURE 13 SLEEP APNEA DEVICES MARKET: STUDY ASSUMPTIONS
• FIGURE 14 SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
• FIGURE 15 SLEEP APNEA DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 16 SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION)
• FIGURE 17 SLEEP APNEA DEVICES MARKET, BY GENDER, 2024 VS. 2029 (USD MILLION)
• FIGURE 18 SLEEP APNEA DEVICES MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
• FIGURE 19 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS TO DRIVE MARKET
• FIGURE 20 THERAPEUTIC DEVICES SEGMENT TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
• FIGURE 21 US AND THERAPEUTIC DEVICES SEGMENT ACCOUNTED FOR LARGER MARKET SHARES IN 2023
• FIGURE 22 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
• FIGURE 23 SLEEP APNEA DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 24 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
• FIGURE 25 SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION TO BE PREFERRED STRATEGY OF PROMINENT COMPANIES
• FIGURE 26 SLEEP APNEA DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA DEVICES
• FIGURE 28 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA DEVICES
• FIGURE 29 SLEEP APNEA DEVICES MARKET: ECOSYSTEM MAP
• FIGURE 30 TOP 10 COMPANIES WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014-2023
• FIGURE 31 REVENUE SHIFT IN SLEEP APNEA DEVICES MARKET
• FIGURE 32 INVESTMENT & FUNDING SCENARIO FOR KEY PLAYERS (2018-2023)
• FIGURE 33 SLEEP APNEA DEVICES MARKET: PRESCRIPTION PATTERN ASSESSMENT
• FIGURE 34 NORTH AMERICA: SLEEP APNEA DEVICES MARKET SNAPSHOT
• FIGURE 35 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET SNAPSHOT
• FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN SLEEP APNEA DEVICES MARKET, 2021-2023 (USD MILLION)
• FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SLEEP APNEA DEVICES MARKET (2023)
• FIGURE 38 SLEEP APNEA DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
• FIGURE 39 SLEEP APNEA DEVICES MARKET: COMPANY FOOTPRINT
• FIGURE 40 SLEEP APNEA DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
• FIGURE 41 EV/EBITDA OF KEY VENDORS
• FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• FIGURE 43 SLEEP APNEA DEVICES MARKET: PRODUCT COMPARATIVE ANALYSISFOR CPAP DEVICES
• FIGURE 44 RESMED: COMPANY SNAPSHOT (2023)
• FIGURE 45 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)
• FIGURE 46 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2024)
• FIGURE 47 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2023)
• FIGURE 48 SOMNOMED: COMPANY SNAPSHOT (2023)
• FIGURE 49 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2023)
• FIGURE 50 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY SNAPSHOT (2023)